Low bFGF Levels Linked to Poor Prognosis in Breast Cancer
Author Information
Author(s): R Colomer, J Aparicio, S Montero, C Guzman, L Larrodera, H Cortes-Funes
Primary Institution: Hospital Universitario Doce de Octubre
Hypothesis
Do low levels of basic fibroblast growth factor (bFGF) correlate with poor prognosis in breast carcinoma?
Conclusion
Low levels of bFGF in breast carcinoma are associated with a significantly shorter disease-free survival.
Supporting Evidence
- Low bFGF levels were found in 54% of patients who relapsed compared to 17% who did not.
- Patients with low bFGF had a significantly shorter disease-free survival.
- Low bFGF levels correlated with larger tumor size and more advanced disease stage.
Takeaway
If a patient with breast cancer has low bFGF levels, they might have a harder time staying cancer-free after treatment.
Methodology
The study measured bFGF levels in breast tumor cytosols using an immunoassay and followed patients for disease relapse.
Limitations
The study did not assess overall survival as a primary endpoint.
Participant Demographics
The study included 140 patients with breast carcinoma or benign breast conditions, median age 57 years.
Statistical Information
P-Value
0.002
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website